Register for a Biocartis Idylla live demonstration at ADIAP Conference
The fully automated IdyllaTM EGFR Mutation Test delivers results in 2.5h for 51 mutations in exons 18–21 using only 1 FFPE tissue section from metastatic NSCLC.
08May
02May
Asuragen announce the launch of AmplideX® PCR/CE HTT kit for Huntington’s disease
Abacus dx would like to update you with the latest product from Asuragen.
17Apr
Remember to use the “Streck Tube”, the most trusted preanalytical solution for cell free DNA
For all liquid biopsies, remember to use the “Streck Tube”, the No.1 tube worldwide for stabilisation of cell free DNA.
02Apr
Register for a Biocartis Idylla live demonstration at ASDG Conference
The fully automated IdyllaTM EGFR Mutation Test delivers results in 2.5h for 51 mutations in exons 18–21 using only 1 FFPE tissue section from metastatic NSCLC.
12Mar
Biocartis announces CE-IVD marking of its Idylla™ MSI Test
Biocartis Group NV, an innovative molecular diagnostics company (Euronext Brussels: BCART), today announces the CE-IVD marking of its fully automated Idylla™ MSI Test which allows for fast and accurate information on a patient’s MSI status directly from a single sample of FFPE[1] colorectal cancer tumor tissue. This CE-IVD launch is a key addition to Biocartis’ colorectal cancer (CRC) Idylla™ test menu as MSI detection is currently recommended for all patients with CRC[2].
28Feb
Streck liquid biopsy-based cancer research webinar
Recent Advances and Challenges in Liquid Biopsy-Based Cancer Research
Abacus dx is happy to be able to present to you a Streck-sponsored on-demand webinar presented by Prof. Dr. med. Stefan Holdenrieder.
25Feb
Idylla EGFR Mutation Test (CE-IVD)
Biocartis is pleased to add a new Idylla EGFR (Epidermal Growth Factor Receptor) Mutation Test to their core oncology menu, that now covers most known and used oncology biomarkers.
20Feb
Register for a live demonstration at RCPA Pathology Update
The fully automated IdyllaTM EGFR Mutation Test delivers results in 2.5h for 51 mutations in exons 18–21 using only 1 FFPE tissue section from metastatic NSCLC.
18Feb
ZytoVision FISH Probes for Lung Cancer
ZytoVision’s ZytoLight® products are designed for the identification of genetic aberrations eg. translocations, deletions, amplifications and chromosomal aneuploidies by Fluorescence in situ Hybridisation (FISH) in formalin-fixed, paraffin-embedded tissue sections, cell samples, blood or bone marrow smears and metaphase chromosome spreads.